HUDDINGE, Sweden--(BUSINESS WIRE)--Regulatory News:
Medivir AB (STO:MVIR-B):
Financial summary Second quarter 2015 (2014)
· Net turnover totalled SEK 245.8 million (564.0 m), of which SEK 165.6 million (500.7 m) comprised second quarter royalties for simeprevir.
Help employers find you! Check out all the jobs and post your resume.
